Ten-year follow-up of infliximab treatment for uveitis in Behçet disease patients: A multicenter retrospective study.

Frontiers in medicine(2023)

引用 1|浏览8
暂无评分
摘要
Among BD patients with uveitis who initiated IFX, approximately 75% continued treatment for 10 years, and their VA improved significantly and was maintained for 10 years. Uveitis recurred in one-half of the patients, but visual acuity did not differ significantly from the patients without recurrence.
更多
查看译文
关键词
Behçet disease,Behçet uveitis,biologics,endogenous uveitis,infliximab,non-infectious uveitis,uveitis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要